本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

诺和诺德

74.63
+1.982.73%
盘后74.800.1700+0.23%19:59 EDT
成交量:954.99万
成交额:7.13亿
市值:3,312.87亿
市盈率:21.94
高:75.16
开:74.15
低:73.97
收:72.65
数据加载中...
2025/05/30

关联方拟减持公告

Form 144 | Innate Pharma SA 10% 股东 Novo Nordisk A/S 拟减持921897股,总价约197万美元
2025/02/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/06/21

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/06/21

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2024/01/31

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/11/24

SEC问询函

Form CORRESP - Correspondence
2023/11/09

SEC问询函

Form CORRESP - Correspondence
2023/10/20

SEC问询函

Form CORRESP - Correspondence
2023/09/29

SEC问询函

Form CORRESP - Correspondence
2023/09/13

SEC问询函

Form CORRESP - Correspondence
2023/06/28

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/06/28

员工持股计划

Form 11-K - Annual report of employee stock purchase, savings and similar plans
2023/02/01

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/06/28

员工持股计划

11-K [Paper] - Annual report of employee stock purchase, savings and similar plans
2022/06/28

员工持股计划

11-K [Paper] - Annual report of employee stock purchase, savings and similar plans
2022/03/24

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/02

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/06/23

员工持股计划

11-K [Paper] - Annual report of employee stock purchase, savings and similar plans
2021/06/23

员工持股计划

11-K [Paper] - Annual report of employee stock purchase, savings and similar plans
2021/05/05

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]